[Betalactam resistant Streptococcus pneumoniae and management of pneumococcal meningitis].
Garau
Javier
J
Martínez-Lacasa
Xavier
X
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D006801:Humans; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy*; D008667:Metalloproteins / Q000627:therapeutic use; D009345:Neisseria meningitidis / Q000187:drug effects; D013030:Spain; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D018074:Vaccines, Conjugate / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D008667:Metalloproteins; D018074:Vaccines, Conjugate; D003907:Dexamethasone; D002439:Cefotaxime